ISRS delivers its 100th Webinar
Since we launched our webinar program in Oct 2016 we have delivered webinars on a fortnightly basis covering important topics related to intracranial and body SRS. These have become increasingly popular during the pandemic attracting hundreds of registrants. We have now completed our 100th webinar. This has all been made possible due to the generosity of the speakers who have given up their time to give high level lectures. Members can access recording of all of the webinars via our website: Access the library here.
Stereotactic Radiation and Hypofractionation in Gynecological Cancers
Radiation Oncologist, Odette Cancer Centre
Associate Professor, Department of Radiation Oncology
Gynecological Oncology, Radiation Site Lead
University of Toronto
Sunnybrook Health Sciences Centre
Odette Cancer Centre, Toronto, Canada
March 02, 2021, 1:00PM BST
The objectives of this webinar are:
- To review the indications for stereotactic radiation ablative radiation (SABR) and hypofractionation for gynecological (GYN) cancers
- To review existing literature on SABR in GYN
- To review the potential role of hypofractionation in GYN cancers
- To discuss innovations and research in hypofractionation for GYN cancers
Stereotactic Body Radiation Therapy for Primary and Metastatic Kidney Cancer
Assistant Professor in Radiotherapy
Department of Biomedical Sciences
Humanitas University Radiotherapy and Radiosurgery Department
Humanitas Research Hospital, Rozzano MI, Italy
March 18, 2021, 1:00PM BST
Kidney represents a frequent site of malignant tumors, with clear cell renal carcinoma as the most represented histology. Surgical resection is recommended for renal cancers, while radiofrequency ablation (RFA) may be a considered an alternative for small lesions. Stereotactic body radiation therapy (SBRT) represents nowadays a promising option also in this setting. Thanks to its proved efficacy and non-invasiveness, SBRT may be considered an attractive approach both for patients not candidate to surgery or ablation, and also in the multidisciplinary management of the oligometastatic disease.
Radiation Therapy for Glioma on the MR-Linac
Assistant Professor, University of Toronto
Department of Radiation Oncology
Sunnybrook Health Sciences Centre, Toronto, ON Canada
April 08, 2021, 1:00pm BST
With the recent development of MR-guided radiotherapy systems, specifically integrated MRI-linear accelerator systems, the precision of radiation treatment could be improved. Radiation therapy for glioma on the MR-linac allows direct visualization of normal tissues and tumor-related changes and the potential for functional image acquisition to facilitate early outcome prediction. This ISRS webinar will provide an overview of workflow and early clinical experiences of radiation therapy for glioma on the MR-linac.
Molecular Profiling in Gliomas: Current Applications and Future Directions
Neurologist, Sunnybrook Health Sciences Centre
Clinician Investigator, Faculty of Medicine, University of Toronto, Canada
June 04, 2021, 1:00PM BST
Advances in next generation sequencing has brought molecular profiling to the forefront of clinical care in glioma patients. This presentation will review the emerging clinical applications of molecular profiling of gliomas and review their predictive and prognostic utility. It will also specifically discuss the importance of molecular profiling in young adult glioma patients and discuss emerging targeted therapy options.